Delivery Order SPE2DX15D9223-SPE2DX22FQUGC

Award Date 10/27/21
Potential Completion Date 10/28/21
Potential Value $4.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. under an indefinite-delivery/indefinite-quantity contract vehicle. The order is for 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $12,934.05. Performance will take place in Park Ridge, Illinois with completion by March 23, 2023. No set-aside provision was applied to this order. The DLA supports military readiness by procuring and providing medical supplies and pharmaceuticals to armed...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE. The order has a potential value of $77,604.30 under a firm fixed price arrangement. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 16, 2023. No set-aside designation was applied to this award made in support of the Defense Logistics Agency's pharmaceutical procurement and distribution programs.
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. The order is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to a location in Park Ridge, Illinois. XTANDI is used to treat men with prostate cancer. The period of performance for this order is from August 29, 2023 through August 30, 2023. No subcontractors or set aside designations were...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $12,934.05. Performance will occur in Park Ridge, Illinois, with delivery required by May 30, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support for the U.S. military, this order is likely intended to...
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois with completion by May 5, 2023. The firm fixed price contract was awarded on May 4, 2023 without a set-aside designation. As the DLA supports military treatment facilities, this order for the prostate...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $8,643.02. The place of performance is Park Ridge, Illinois and all items are to be delivered by November 10, 2022. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement, distribution and supply chain management for the...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $12,964.50. The place of performance is Park Ridge, Illinois and all items are to be delivered by December 12, 2022. No set-aside designation was used for this order placed under an existing DLA pharmaceutical supply contract vehicle. As the Defense Logistics Agency's primary role includes procuring, managing and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $8,622.72 by the Defense Logistics Agency Troop Support Medical to supply 120 capsules of XTANDI 40 MG CAPSULE. The delivery order was issued against the prime vendor's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to provide various pharmaceutical items and medical supplies. DMS Pharmaceutical Group will deliver the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand nine hundred thirty-four dollars and five cents ($12,934.05) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois and the period of performance is September 7-8, 2023. No set aside designation or subcontractors are indicated. This order is likely placed against DLA's...
This firm fixed price delivery order, valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35), was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. The place of performance will be Park Ridge, Illinois for the period of September 18, 2023 through September 19, 2023. No set aside designation or subcontractors were identified. DLA supports the...
  • SPE2DX15D9223
    Indefinite Delivery Contract
  • SPE2DX15D9223-SPE2DX22FQUGC
    Delivery Order

4555235131 ! XTANDI 40 MG CAPSULE 120S

Posted 10/27/21